212 related articles for article (PubMed ID: 10481811)
1. [Antimicrobial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections. Part III].
Matsumoto Y; Ishihara R; Suzuki Y; Nishinari C; Ishii Y; Nakane Y; Endo H
Jpn J Antibiot; 1999 Jun; 52(6):469-77. PubMed ID: 10481811
[TBL] [Abstract][Full Text] [Related]
2. [Antibacterial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections (II)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1994 Dec; 47(12):1753-61. PubMed ID: 7877255
[TBL] [Abstract][Full Text] [Related]
3. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
5. [Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003].
Wang H; Yu YS; Liu Y; Li HY; Hu BJ; Sun ZY; Chen MJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):155-60. PubMed ID: 15130324
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II].
Shimada J; Ishihara R; Suzuki Y; Ishii Y; Nakazawa A; Deguchi K
Jpn J Antibiot; 1997 Sep; 50(9):756-67. PubMed ID: 9394236
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients].
Ishihara R; Ishii Y; Suzuki Y; Nakazawa A; Deguchi K; Toyonaga Y
Jpn J Antibiot; 1998 Jan; 51(1):1-10. PubMed ID: 9557272
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections].
Shimada J; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Deguchi K
Jpn J Antibiot; 1995 Jul; 48(7):949-59. PubMed ID: 7563588
[TBL] [Abstract][Full Text] [Related]
10. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
Melo-Cristino J; Fernandes ML; Serrano N;
Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to moxifloxacin and other antimicrobial agents of major pathogens responsible for community acquired respiratory tract infection in Poland.
Betlejewska K; Hryniewicz W
Int J Antimicrob Agents; 2002 Jan; 19(1):47-52. PubMed ID: 11814767
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy.
Stefani S; Mezzatesta ML; Fadda G; Mattina R; Palù G; Rossano F; Tufano MA; Schito GC; Nicoletti G
J Chemother; 2008 Oct; 20(5):561-9. PubMed ID: 19028617
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
15. [Drug susceptibility of bacteria isolated from pediatric respiratory infections at general practitioners' clinics to pediatric antibiotics].
Hirakata Y; Komatsu M; Muratani T; Kaku M
Jpn J Antibiot; 2009 Apr; 62(2):90-102. PubMed ID: 19673351
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001.
Stratton CW; Brown SD
Clin Ther; 2004 Apr; 26(4):522-30. PubMed ID: 15189749
[TBL] [Abstract][Full Text] [Related]
18. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
Nishioka K; Ogihara H; Ohno I; Shirato K
Jpn J Antibiot; 1997 Sep; 50(9):768-75. PubMed ID: 9394237
[TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolated in major hospitals in Nagano Prefecture].
Yamazaki Y; Yagi H; Kubo K; Morita M; Hirayama J; Hayasaka M; Harada K; Honda T; Hirai K; Yanagisawa H
Jpn J Antibiot; 2002 Oct; 55(5):524-36. PubMed ID: 12532636
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
